Anne E. Cress, PhD

Interim Director, University of Arizona Cancer Center

Professor, Cellular and Molecular Medicine, Radiation Oncology

Deputy Dean for Research and Academic Affairs, College of Medicine

E-Mail Address: 
Phone Number: 
(520) 626-7553
Fax: 
(520) 626-4979
Short Bio: 

Dr. Cress is a Professor in the Department of Cellular and Molecular Medicine and Deputy Dean for Research and Academic Affairs at the College of Medicine at the University of Arizona. Her research interests include investigating the regulation of cell surface molecules called integrins and defective cell adhesion to the extracellular matrix in disease processes and tissue damage responses. The practical application of the work has resulted in several patent awards on new anti-adhesion peptides that are currently being tested for their ability to prevent cancer metastasis and to sensitize cancer to currently available therapies. Dr. Cress has a 25-year history of contributing to interdisciplinary research through the publication of more than 100 original research articles. Her national service includes permanent membership on scientific study sections including those organized by NIH, the Department of Defense and the American Cancer Society. 

Research Information
Research Program: 
3. Cancer Biology
Member Status: 
Member
Year of Membership Acceptance: 
1987
Selected Publications: 
  1. Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells.

    Vrba L, Jensen TJ, Garbe JC, Heimark RL, Cress AE, Dickinson S, Stampfer MR, Futscher BW. PLoS One. 2010 Jan 13;5(1):e8697.PMID: 20084174 [PubMed - in process]Related articlesFree article
     
  2. HYD1-induced increase in reactive oxygen species leads to autophagy and necrotic cell death in multiple myeloma cells.

    Nair RR, Emmons MF, Cress AE, Argilagos RF, Lam K, Kerr WT, Wang HG, Dalton WS, Hazlehurst LA.  Mol Cancer Ther. 2009 Aug;8(8):2441-51. Epub 2009 Aug 11.PMID: 19671765 [PubMed - indexed for MEDLINE]Related articles
     
  3. Transient dephosphorylation of p53 serine 376 as an early response to ionizing radiation.

    Warters RL, Gaffney DK, Kramer GF, Martinez JD, Cress AE.Radiat Res. 2009 Jun;171(6):725-34.PMID: 19580479 [PubMed - indexed for MEDLINE]Related articles
     
  4. Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis.

    Ports MO, Nagle RB, Pond GD, Cress AE.  Cancer Res. 2009 Jun 15;69(12):5007-14. Epub 2009 Jun 2.PMID: 19491258 [PubMed - indexed for MEDLINE]Related articles
     
  5. The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model.

    King TE, Pawar SC, Majuta L, Sroka IC, Wynn D, Demetriou MC, Nagle RB, Porreca F, Cress AE.  PLoS One. 2008;3(10):e3535. Epub 2008 Oct 28.PMID: 18958175 [PubMed - indexed for MEDLINE]Related articlesFree article
Professional Information
Honors: 

1999 - Outstanding Research Investigator Award, Moffitt Cancer Center

2005 - Arizona Health Sciences Center Founder’s Day Award, University of Arizona

2005 - Elkin Award for Cancer Biology Research, Emory University

2008 - Sydney E. Salmon Award, Senior Investigator, Arizona Cancer Center, University of Arizona

Academic Information
Doctorate: 
PhD, Biochemistry/Molecular Biology, University of Arizona
Undergraduate School: 
BS, Microbiology/Chemistry, University of Arizona